Title |
Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?
|
---|---|
Published in |
Osteoporosis International, September 2011
|
DOI | 10.1007/s00198-011-1755-2 |
Pubmed ID | |
Authors |
N. B. Watts, C. Roux, J. F. Modlin, J. P. Brown, A. Daniels, S. Jackson, S. Smith, D. J. Zack, L. Zhou, A. Grauer, S. Ferrari |
Abstract |
Serious adverse events of infections that occurred in subjects receiving denosumab or placebo in the Fracture Reduction Evaluation of Denosumab in Osteoporosis every 6 Months (FREEDOM) study were examined in detail. Serious adverse events of infections in denosumab subjects had heterogeneous etiology, with no clear clinical pattern to suggest a relationship to time or duration of exposure to denosumab. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Malaysia | 1 | 20% |
Australia | 1 | 20% |
United States | 1 | 20% |
Unknown | 2 | 40% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 125 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Singapore | 1 | <1% |
Unknown | 124 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 16 | 13% |
Student > Master | 15 | 12% |
Student > Bachelor | 12 | 10% |
Other | 12 | 10% |
Professor > Associate Professor | 10 | 8% |
Other | 32 | 26% |
Unknown | 28 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 65 | 52% |
Agricultural and Biological Sciences | 10 | 8% |
Nursing and Health Professions | 4 | 3% |
Biochemistry, Genetics and Molecular Biology | 3 | 2% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 2% |
Other | 9 | 7% |
Unknown | 32 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2021.
All research outputs
#6,612,914
of 25,732,188 outputs
Outputs from Osteoporosis International
#1,114
of 3,876 outputs
Outputs of similar age
#36,569
of 136,828 outputs
Outputs of similar age from Osteoporosis International
#7
of 36 outputs
Altmetric has tracked 25,732,188 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 3,876 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 136,828 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 36 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.